Table 2.

Risk factors associated with response to DLI for mixed chimerism by transplant donor types

VariablesHR (95% CI)P value
Age at transplant 1.03 (0.97-1.10) .33 
Transplant year   
2005-2009 (reference)   
2010-2015 2.07 (0.76-5.59) .15 
2016-2021 1.29 (0.45-3.67) .64 
Diagnosis   
Nonmalignant (reference)   
ALL 5.93 (1.73-20.27) .005 
AML 5.56 (1.78-17.38) .003 
Other leukemias 3.20 (0.73-14.03) .12 
Days from HCT to DLI 1.00 (1.00-1.00) .57 
CD3+ cell dose (first DLI) 1.02 (0.94-1.09) .65 
VariablesHR (95% CI)P value
Age at transplant 1.03 (0.97-1.10) .33 
Transplant year   
2005-2009 (reference)   
2010-2015 2.07 (0.76-5.59) .15 
2016-2021 1.29 (0.45-3.67) .64 
Diagnosis   
Nonmalignant (reference)   
ALL 5.93 (1.73-20.27) .005 
AML 5.56 (1.78-17.38) .003 
Other leukemias 3.20 (0.73-14.03) .12 
Days from HCT to DLI 1.00 (1.00-1.00) .57 
CD3+ cell dose (first DLI) 1.02 (0.94-1.09) .65 

P values <.05 are in bold font.

Abbreviations are explained in Table 1.

Adjusted for transplant type.

or Create an Account

Close Modal
Close Modal